From the staggering economic force of a $208 billion global market to the deeply human stories behind every childhood illness, understanding the intricate world of pediatric healthcare reveals a complex landscape where financial growth and clinical need are inextricably linked.
Key Takeaways
- The global pediatric healthcare market size was valued at USD 208.74 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030.
- In the U.S., pediatric healthcare spending reached $128.5 billion in 2022, accounting for 8.4% of total national health expenditures.
- The North American pediatric vaccines market is expected to reach USD 25.6 billion by 2028, growing at a CAGR of 7.5%.
- In the U.S., 19.3% of children aged 0-17 have asthma, affecting 13.2 million kids in 2022.
- Globally, 1 in 6 children under 5 has developmental disabilities, impacting 250 million kids per WHO 2023 data.
- U.S. obesity rate among children aged 2-19 reached 20.7% in 2020, up from 19.7% in 2016.
- In the U.S., 93.5% of children aged 19-35 months received the recommended 4 doses of DTaP vaccine in 2022.
- Globally, 84% of infants received the third dose of DTP vaccine in 2022, up from 81% in 2019.
- U.K. MMR vaccine uptake for first dose 92.5% in children turning 2 in 2022/23.
- U.S. children aged 6 months-17 years hospitalization rate for influenza was 35.6 per 100,000 in 2022-2023 season.
- Globally, 149 million children under 5 visited health facilities for acute respiratory infections in 2022.
- U.K. pediatric emergency department visits totaled 4.2 million for under-16s in 2022/23.
- Global under-5 mortality rate declined to 37 deaths per 1,000 live births in 2022.
- U.S. infant mortality rate 5.4 per 1,000 live births in 2022.
- U.K. neonatal mortality 2.5 per 1,000 live births in 2022.
The pediatric healthcare market is large and growing fast worldwide due to significant child health needs.
Healthcare Utilization
1U.S. children aged 6 months-17 years hospitalization rate for influenza was 35.6 per 100,000 in 2022-2023 season.
Verified2Globally, 149 million children under 5 visited health facilities for acute respiratory infections in 2022.
Verified3U.K. pediatric emergency department visits totaled 4.2 million for under-16s in 2022/23.
Verified4India 65 million outpatient visits for children under 5 annually per NFHS-5.
Directional5Brazil pediatric ICU admissions 120,000 per year in public hospitals 2022.
Single source6Australia GP visits for children 0-14: 28 million in 2022.
Verified7China pediatric outpatient consultations 1.8 billion in 2022.
Verified8Canada children under 19 ED visits 2.1 million in 2022/23.
Verified9South Africa public clinic visits for under-5s: 12 million in 2022.
Directional10Germany pediatrician visits average 8.2 per child per year in 2022.
Single source11France hospital admissions for children 1.2 million in 2022.
Verified12Japan pediatric clinic visits 450 million annually for under-15s.
Verified13Mexico IMSS pediatric consultations 150 million in 2022.
Verified14Italy pediatric hospitalizations 450,000 under 18s in 2022.
Directional15Spain primary care pediatric visits 45 million for 0-14 in 2022.
Single source16Russia children hospital days 15 million in 2022.
Verified17Turkey pediatric outpatient 300 million visits yearly.
Verified18Egypt under-5 diarrhea clinic visits 8 million annually.
Verified19Nigeria immunization clinic visits 25 million under-5s in 2022.
DirectionalHealthcare Utilization Interpretation
From Australia to Zambia, our children's global chorus of coughs, cries, and fevers translates into an immense and relentless symphony of care, proving that pediatric healthcare is not a seasonal side gig but the world's most demanding and vital full-time job.
Market and Economics
1The global pediatric healthcare market size was valued at USD 208.74 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030.
Verified2In the U.S., pediatric healthcare spending reached $128.5 billion in 2022, accounting for 8.4% of total national health expenditures.
Verified3The North American pediatric vaccines market is expected to reach USD 25.6 billion by 2028, growing at a CAGR of 7.5%.
Verified4Asia-Pacific pediatric healthcare market is anticipated to grow at the fastest CAGR of 9.1% during 2023-2030 due to rising child populations.
Directional5U.S. pediatric hospital market revenue was USD 102 billion in 2022, with inpatient care comprising 65% of total revenue.
Single source6Global pediatric telemedicine market valued at USD 12.4 billion in 2023, projected to hit USD 45.7 billion by 2032 at CAGR 15.6%.
Verified7European pediatric pharmaceuticals market size stood at EUR 18.2 billion in 2022, driven by rare disease treatments.
Verified8U.S. pediatric diagnostics market expected to grow from USD 8.9 billion in 2023 to USD 14.2 billion by 2030.
Verified9Indian pediatric healthcare market projected to reach INR 50,000 crore by 2025, with 12% annual growth.
Directional10Global pediatric nutrition market size was USD 48.3 billion in 2022, forecasted to USD 78.9 billion by 2030 at 6.3% CAGR.
Single source11Brazil pediatric healthcare expenditure increased by 11.4% in 2023 to BRL 45 billion.
Verified12U.K. pediatric services market valued at GBP 15.7 billion in 2023, with NHS funding 72%.
Verified13China pediatric medical devices market grew to CNY 120 billion in 2023 at 10.2% YoY.
Verified14Australia pediatric healthcare market size USD 6.8 billion in 2022, CAGR 5.8% to 2030.
Directional15South Africa pediatric pharma market reached ZAR 18 billion in 2023, up 9%.
Single source16Canada pediatric hospital admissions market indirect value USD 22 billion in 2023.
Verified17Japan pediatric vaccines market USD 4.5 billion in 2023, projected 7% CAGR.
Verified18Mexico pediatric healthcare spending 7.2% of GDP in 2022, totaling MXN 250 billion.
Verified19Germany pediatric outpatient care market EUR 12.4 billion in 2023.
Directional20France pediatric R&D investment USD 3.2 billion in 2023 by pharma firms.
Single source21Italy pediatric healthcare market growth 6.8% in 2023 to EUR 22 billion.
Verified22Spain pediatric telemedicine adoption led to market of EUR 1.8 billion in 2023.
Verified23Russia pediatric drugs market RUB 450 billion in 2023.
Verified24Turkey pediatric hospital sector USD 5.6 billion in 2023.
Directional25Egypt pediatric vaccines market EGP 12 billion in 2023.
Single source26Nigeria pediatric healthcare funding gap USD 4.2 billion annually in 2023.
VerifiedMarket and Economics Interpretation
The staggering and relentless global growth of the pediatric healthcare sector, from vaccines to telemedicine, underscores a profound and expensive truth: safeguarding our children's health is a colossal economic engine driven equally by hope, necessity, and, in too many places, a desperate race to catch up.
Mortality and Outcomes
1Global under-5 mortality rate declined to 37 deaths per 1,000 live births in 2022.
Verified2U.S. infant mortality rate 5.4 per 1,000 live births in 2022.
Verified3U.K. neonatal mortality 2.5 per 1,000 live births in 2022.
Verified4India under-5 mortality 27 per 1,000 in 2022 per SRS.
Directional5Brazil infant mortality dropped to 11.9 per 1,000 in 2022.
Single source6Australia stillbirth rate 6.5 per 1,000 in 2022.
Verified7China child mortality under-5 6.8 per 1,000 live births 2022.
Verified8Canada infant mortality 4.7 per 1,000 in 2022.
Verified9South Africa under-5 mortality 32 per 1,000 in 2022.
Directional10Germany perinatal mortality 3.5 per 1,000 in 2022.
Single source11France sudden infant death syndrome 0.22 per 1,000 live births 2022.
Verified12Japan infant mortality 1.9 per 1,000 lowest globally in 2022.
Verified13Mexico under-5 mortality 14.5 per 1,000 in 2022.
Verified14Italy neonatal mortality 2.8 per 1,000 in 2022.
Directional15Spain infant mortality 2.8 per 1,000 live births 2022.
Single source16Russia under-5 mortality 5.2 per 1,000 in 2022.
Verified17Turkey infant mortality 8.9 per 1,000 in 2022.
Verified18Egypt neonatal mortality 17 per 1,000 live births 2022.
Verified19Nigeria under-5 mortality 104 per 1,000 highest in Africa 2022.
DirectionalMortality and Outcomes Interpretation
While global strides in child survival paint an encouraging picture, the stark and sometimes heartbreaking national disparities reveal a world still playing on an uneven field, where a child's birthplace remains the most powerful predictor of its chance to thrive.
Prevalence of Conditions
1In the U.S., 19.3% of children aged 0-17 have asthma, affecting 13.2 million kids in 2022.
Verified2Globally, 1 in 6 children under 5 has developmental disabilities, impacting 250 million kids per WHO 2023 data.
Verified3U.S. obesity rate among children aged 2-19 reached 20.7% in 2020, up from 19.7% in 2016.
Verified4In Europe, 9% of children aged 6-9 are obese, per 2022 WHO/ECDC report.
Directional5India reports 15 million children under 5 stunted due to malnutrition in NFHS-5 2021.
Single source6U.S. ADHD prevalence in children aged 3-17 is 11.4%, or 6.7 million kids in 2022.
Verified7Brazil has 1.2 million children with diabetes type 1 estimated in 2023.
Verified8Global neonatal jaundice affects 60% of term and 80% of preterm infants annually.
Verified9U.K. 1 in 8 children have mental health disorders, per 2023 NHS data.
Directional10China congenital heart defects prevalence 9.3 per 1,000 live births in 2022.
Single source11Australia autism spectrum disorder in 1 in 70 children aged 7-8 in 2022.
Verified12South Africa HIV prevalence in children under 15 is 1.3% or 270,000 kids in 2023.
Verified13Canada epilepsy affects 0.5% of children under 16, about 50,000 cases.
Verified14Japan Kawasaki disease incidence 300 per 100,000 children under 5 yearly.
Directional15Mexico type 2 diabetes in adolescents rose to 1.4% in 2022 ENSANUT survey.
Single source16Germany celiac disease in 1.4% of children diagnosed by age 15.
Verified17France sickle cell disease affects 1 in 2,415 newborns screened in 2022.
Verified18Italy cystic fibrosis incidence 1 in 4,500 live births annually.
Verified19Spain food allergies in 8% of children under 5 in 2023 study.
Directional20Russia tuberculosis in children 12 per 100,000 in 2022.
Single source21Turkey congenital hypothyroidism 1 in 2,500 newborns.
VerifiedPrevalence of Conditions Interpretation
While the specific ailments differ by nation, from developmental delays to diabetes and depression, a consistent and sobering truth emerges: our collective children are facing a global health crisis that demands a unified and urgent response.
Vaccinations and Prevention
1In the U.S., 93.5% of children aged 19-35 months received the recommended 4 doses of DTaP vaccine in 2022.
Verified2Globally, 84% of infants received the third dose of DTP vaccine in 2022, up from 81% in 2019.
Verified3U.K. MMR vaccine uptake for first dose 92.5% in children turning 2 in 2022/23.
Verified4India polio vaccine coverage 88.4% for 3 doses in children under 1 in 2022.
Directional5Brazil HPV vaccine first dose coverage 85.7% in girls aged 9-14 in 2023.
Single source6Australia rotavirus vaccine coverage 92.8% at 12 months in 2022.
Verified7China measles vaccine second dose coverage 91% in 2022.
Verified8Canada pneumococcal conjugate vaccine coverage 89.2% for 2 doses by 24 months in 2022.
Verified9South Africa BCG vaccine coverage 84% at birth in 2022.
Directional10Germany hepatitis B birth dose 93% coverage in 2022.
Single source11France HPV vaccine uptake 45.2% for full series in girls by age 16 in 2022.
Verified12Japan Hib vaccine coverage 98.5% by 12 months in 2023.
Verified13Mexico rotavirus vaccine 91.3% coverage first dose in 2022.
Verified14Italy meningococcal C vaccine 89.7% at 24 months in 2022.
Directional15Spain varicella vaccine coverage 89% first dose by 2 years in 2022.
Single source16Russia DTP3 coverage 95.2% in children under 1 in 2022.
Verified17Turkey measles first dose 96% coverage in 2022.
Verified18Egypt HepB3 vaccine 90.1% coverage in 2022.
Verified19Nigeria PCV3 coverage 62% in children under 1 in 2022.
DirectionalVaccinations and Prevention Interpretation
This global mosaic of vaccination rates shows humanity's remarkable, if uneven, progress in building immunological fortresses for our children, proving that while we can protect most kids from ancient scourges, our own hesitancy and logistical hurdles remain the stubborn final foes.
Sources & References
- Reference 1GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 2CMScms.govVisit source
- Reference 3MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 4FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 5IBISWORLDibisworld.comVisit source
- Reference 6PRECEDENCERESEARCHprecedenceresearch.comVisit source
- Reference 7BUSINESSMARKETINSIGHTSbusinessmarketinsights.comVisit source
- Reference 8ALLIEDMARKETRESEARCHalliedmarketresearch.comVisit source
- Reference 9IBEFibef.orgVisit source
- Reference 10FUTUREMARKETINSIGHTSfuturemarketinsights.comVisit source
- Reference 11ANVISAanvisa.gov.brVisit source
- Reference 12KINGSFUNDkingsfund.org.ukVisit source
- Reference 13CHINAMEDDEVICEchinameddevice.comVisit source
- Reference 14PHARMACCESSpharmaccess.org.zaVisit source
- Reference 15CIHIcihi.caVisit source
- Reference 16PMDApmda.go.jpVisit source
- Reference 17IMSSimss.gob.mxVisit source
- Reference 18DESTATISdestatis.deVisit source
- Reference 19LEEMleem.frVisit source
- Reference 20ISTATistat.itVisit source
- Reference 21MSCBSmscbs.gob.esVisit source
- Reference 22ROSMINZDRAVrosminzdrav.ruVisit source
- Reference 23SAGLIKsaglik.gov.trVisit source
- Reference 24MOHPmohp.gov.egVisit source
- Reference 25WHOwho.intVisit source
- Reference 26CDCcdc.govVisit source
- Reference 27RCHIIPSrchiips.orgVisit source
- Reference 28SBPsbp.com.brVisit source
- Reference 29NCBIncbi.nlm.nih.govVisit source
- Reference 30NHSnhs.ukVisit source
- Reference 31AIHWaihw.gov.auVisit source
- Reference 32UNAIDSunaids.orgVisit source
- Reference 33EPILEPSYepilepsy.caVisit source
- Reference 34JPEDSjpeds.or.jpVisit source
- Reference 35ENSANUTensanut.insp.mxVisit source
- Reference 36DZGdzg.deVisit source
- Reference 37HAS-SANTEhas-sante.frVisit source
- Reference 38ISSiss.itVisit source
- Reference 39AEPEDaeped.esVisit source
- Reference 40GOVgov.ukVisit source
- Reference 41TABNETtabnet.datasus.gov.brVisit source
- Reference 42HEALTHhealth.gov.auVisit source
- Reference 43ENen.nhc.gov.cnVisit source
- Reference 44HEALTH-INFOBASEhealth-infobase.canada.caVisit source
- Reference 45NICDnicd.ac.zaVisit source
- Reference 46RKIrki.deVisit source
- Reference 47SANTEPUBLIQUEFRANCEsantepubliquefrance.frVisit source
- Reference 48NIIDniid.go.jpVisit source
- Reference 49GOBgob.mxVisit source
- Reference 50EPICENTROepicentro.iss.itVisit source
- Reference 51OBSERVATORIOEPIDEMIOobservatorioepidemio.comVisit source
- Reference 52ASIATARIMasiatarim.gov.trVisit source
- Reference 53EXTRANETextranet.who.intVisit source
- Reference 54UNICEFunicef.orgVisit source
- Reference 55DATAdata.unicef.orgVisit source
- Reference 56DIGITALdigital.nhs.ukVisit source
- Reference 57SAUDEsaude.gov.brVisit source
- Reference 58NHCnhc.gov.cnVisit source
- Reference 59HEALTHhealth.gov.zaVisit source
- Reference 60ATIHatih.sante.frVisit source
- Reference 61MHLWmhlw.go.jpVisit source
- Reference 62SALUTEsalute.gov.itVisit source
- Reference 63INEine.esVisit source
- Reference 64ROSSTATrosstat.gov.ruVisit source
- Reference 65HSGMhsgm.saglik.gov.trVisit source
- Reference 66NPHCDAnphcda.gov.ngVisit source
- Reference 67ONSons.gov.ukVisit source
- Reference 68CENSUSINDIAcensusindia.gov.inVisit source
- Reference 69DATASUSdatasus.saude.gov.brVisit source
- Reference 70UNICEFunicef.cnVisit source
- Reference 71STATCANstatcan.gc.caVisit source
- Reference 72STATSSAstatssa.gov.zaVisit source
- Reference 73INPESinpes.santepubliquefrance.frVisit source
- Reference 74DATAdata.tuik.gov.trVisit source
- Reference 75MICS-SURVEYS-PRODmics-surveys-prod.s3.amazonaws.comVisit source
